Veraxa Biotech shareholders approved all proposals at extraordinary general meetingPUBT·8 hours agoVRXA-3.23%
VERAXA Biotech Shareholders Approve All Proposals at Extraordinary General Meeting, Strengthening Strategic Flexibility for Future Growth | VRXA Stock NewsStockTitan·16 hours agoVRXA-3.23%
Veraxa Biotech names Christoph Erkel chief scientific officer, succeeding Rick AustinPUBT·1 day ago, 06:02 AMVRXA-3.23%
Veraxa Biotech receives PEI scientific advice on BiTAC-TCE development planPUBT·Jul 20 at 06:01 AMVRXA-3.23%
VERAXA Biotech (NASDAQ: VRXA) Partners With Ardigen to Advance AI-Driven Cancer Drug Developmentbusinessinsider·Jul 13 at 12:15 PMVRXA-3.23%
AI Chips Today - AI Advancements Revolutionize Drug Discovery and Cancer TreatmentSimplywall·Jul 13 at 08:16 AMMU-6.99%SKHY-8.81%
Veraxa Biotech partners with Ardigen on AI-enabled drug discovery for BiTAC pipelinePUBT·Jul 13 at 06:00 AMVRXA-3.23%
FB Financial, Smith Micro Software And 3 Stocks To Watch Heading Into Mondaybenzinga_article·Jul 13 at 01:35 AMLGPS-1.26%VRXA-3.23%
Veraxa Biotech names Carl von Halem interim CFO, replacing Torsten BürgermeisterPUBT·Jul 10 at 03:22 PMVRXA-3.23%
VERAXA Biotech (NASDAQ: VRXA) Advances Lead BiTAC(R) T-Cell Engager Program with Cell Line Development Partnershipbusinessinsider·Jul 9 at 12:45 PMVRXA-3.23%
